This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. There has been little work done in pharmacogenetics and insulin resistance which is an associated factor in PCOS (Polycystic Ovary Syndrome) indicating a need for insulin resistance pharmacogenetic studies. We plan to use haplotypes as a means to uncover the relation between specific variants in candidate genes and the response to metformin therapy.
Showing the most recent 10 out of 1232 publications